New Insights into How Gut Microbes Trigger Immune Tolerance via Bacterial Sensor STING
Discover how the bacterial sensor protein STING plays a pivotal role in promoting immune tolerance to gut microbes, offering new insights into intestinal health and potential treatments for inflammatory bowel disease.
Recent research from Weill Cornell Medicine has uncovered a crucial mechanism behind immune tolerance to the vast community of microbes residing in the human gut. The study highlights the role of an ancient bacterial sensor protein known as STING, traditionally associated with promoting inflammation, in mediating immune tolerance within the gut lining. This discovery offers a fresh perspective on how the immune system distinguishes beneficial microbes from harmful pathogens.
The research focused on innate lymphoid cells, particularly ILC3s, which inhabit the mucosal lining of the intestines. Previously, it was established that these cells prevent immune attacks on gut bacteria, but the new findings reveal that their ability to do so heavily depends on STING signaling. Moderate activation of STING prompts ILC3s to induce immune tolerance, allowing beneficial microbes to coexist peacefully. Conversely, excessive STING activity can lead to the death of these cells, resulting in a breakdown of this tolerance and increased inflammation.
The team demonstrated that in mice, gut ILC3s sense bacteria through STING, which, despite its known pro-inflammatory role, in this context encourages immune cells to migrate to lymph nodes and promote regulatory T cells that dampen immune responses. When STING was deleted from ILC3s, mice showed heightened susceptibility to bacterial-induced gut inflammation. Interestingly, in inflammatory conditions such as inflammatory bowel disease (IBD), overactive STING signaling was observed, correlating with ILC3 depletion.
This research helps reconcile previous conflicting views on STING's role in gut health, suggesting that its impact depends on the level of activation. The findings open up potential therapeutic avenues, where modulating STING activity could restore tolerance and prevent or treat gut inflammation. Targeting this pathway may also help replace lost ILC3s, offering hope for novel treatments against inflammatory bowel diseases.
Overall, this study advances our understanding of the mammalian immune system’s adaptation to gut microbes and underscores the importance of balanced STING signaling in maintaining intestinal health.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Timing of Hormone Replacement Therapy Key to Alzheimer's Disease Risk
New research suggests that starting hormone replacement therapy within five years of menopause can reduce Alzheimer's disease risk, while delaying treatment may increase it, emphasizing the importance of timing.
New Guidelines Enhance Diagnosis and Treatment of Inflammatory Bowel Disease
Updated guidelines developed by the University of Nottingham aim to help clinicians diagnose and treat inflammatory bowel disease more accurately and rapidly, emphasizing early, effective therapy for better patient outcomes.
Twin Study Reveals Mitochondria's Role in Regulating Genes Linked to Obesity
Research on Finnish twins uncovers how mitochondrial quantity influences gene activity linked to obesity, shedding light on metabolic mechanisms that contribute to weight gain and potential personalized treatments.
Australian Research Reinforces That Attempting to Suppress or Alter Gender Identity is Ineffective and Harmful
New Australian research confirms that efforts to suppress or alter a child's gender identity are ineffective and can cause long-term psychological harm. These findings challenge outdated practices and support affirming care for gender-diverse youth.